ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Pharmacosmos Therapeutics INC.

Official 2024 U.S. DOL Form 5500 summary for Pharmacosmos Therapeutics INC. (Pharmacosmos Therapeutics Retirement Plan · EIN 38-4128963 · PN 001): $15.27M net assets, 220 active participants, and $3.23 per $10,000 (3.23 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorPharmacosmos Therapeutics INC.
Filing IdentifierPharmacosmos Therapeutics Retirement Plan · EIN 38-4128963 · PN 001
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$15.27M
Active Participants220
Direct Admin Fee Rate$3.23 per $10,000 (3.23 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderStrategicadvisorsinc
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($134,866, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI